Deoras Mukul
Director · WH
As of 2026-09-16, Deoras Mukul has 15 Form 4 transactions on record across 1 company — 8 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
- Direct $1.7M
- Indirect $0
| WH | direct | 25,127 sh | $1.7M |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|
15 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-07-24 | WH | Award / grant | 574 | 25,127 | Form 4 |
| 2026-05-01 | WH | Award / grant | 518 | 24,553 | Form 4 |
| 2026-03-10 | WH | Award / grant | 326 | 24,035 | Form 4 |
| 2026-03-09 | WH | Award / grant | 1,639 | 4,044 | Form 4 |
| 2026-03-03 | WH | Award / grant | 300 | 23,709 | Form 4 |
| 2026-03-01 | WH | Award / grant | 850 | 23,409 | Form 4 |
| 2026-02-20 | WH | Award / grant | 484 | 22,559 | Form 4 |
| 2025-10-24 | WH | Award / grant | 540 | 22,075 | Form 4 |
| 2025-07-25 | WH | Award / grant | 437 | 21,535 | Form 4 |
| 2025-05-02 | WH | Award / grant | 460 | 21,098 | Form 4 |
| 2025-03-10 | WH | Award / grant | 316 | 20,638 | Form 4 |
| 2025-03-03 | WH | Award / grant | 1,176 | 3,813 | Form 4 |
| 2025-03-01 | WH | Award / grant | 828 | 20,322 | Form 4 |
| 2025-02-27 | WH | Award / grant | 402 | 19,494 | Form 4 |
| 2025-02-14 | WH | Award / grant | 353 | 19,092 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.